(lp0
S"Aradigm Corp.  Announces Mixed Results from Two Pulmaquin Phase 3s in ... StreetInsider.com - Dec 1, 2016 Aradigm Corporation  announced top-line results from its two Phase 3 clinical trials  evaluating the safety and efficacy of Pulmaquin, the Company's investigational proprietary formulation of once daily ciprofloxacin ...Aradigm's inhaled antibiotic fails late-stage study, shares sink - Reuters"
p1
aS'1.51 MarketWatch - Apr 21, 2011 22, 2016 at 4:15 p.m. ET; on InvestorPlace.com. 3 Reasons Why Aradigm Corporation  is a Great Momentum Stock. Sep. 22, 2016 at 9:11 a.m.'
p2
aS'6 Reasons Aradigm Corporation Is An Excellent Risk Vs. Reward Opportunity Seeking Alpha  - Aug 8, 2014 Yet, we managed to discover an intriguing biotech small cap with an excellent risk vs. reward profile called Aradigm Corporation . This company possesses exactly the right features that made us aggressively buy shares in the open market:.'
p3
aS"3 Reasons Why Aradigm Corporation  is a Great Momentum Stock September ... Zacks.com - Sep 22, 2016 This method discovered several great candidates for momentum-oriented investors, but today let's focus in on Aradigm Corporation  as this stock is looking especially impressive right now. And while there are numerous ways in which&nbsp;..."
p4
aS"Don't Write Off Aradigm Corporation  Just Yet Market Exclusive - Dec 2, 2016 A number of small cap biotech companies took a hit on their market capitalization on Thursday, but none more sharply than Aradigm Corporation . The company put out some data relating to its lead investigational asset, Pulmaquin, and&nbsp;...Pulmaquin failure halves Aradigm's value - The Pharma Letter "
p5
aS"Aradigm Corporation  Files An 8-K Notice of Delisting or Failure ... Market Exclusive - Apr 10, 2017 On April 4, 2017, Aradigm Corporation  received a notice from The NASDAQ Capital Market  that the Company is not in compliance with NASDAQ's Listing Rule 5550, as it has not maintained a minimum of $2,500,0000 in its&nbsp;..."
p6
aS"Breaking Down: Aradigm Corporation  Stock Drop Below Support ... CML News - Mar 30, 2017 Aradigm Corporation has a one bull  technical rating because it's trading below the 10 day, 50 day and 200 day simple moving averages while the 10-day moving average is below the 50-day moving average and the 50-day moving&nbsp;..."
p7
aS'Grifols, SA and Aradigm Corporation Announce Signing of Worldwide Licensing ... Business Wire  - May 21, 2013 BARCELONA, Spain &amp; HAYWARD, Calif.----Grifols, S.A.   and Aradigm Corporation   today announced the signing of an exclusive, worldwide license&nbsp;...'
p8
aS"The Market Is Underestimating The Potential Of Aradigm's Lead Product Candidate Seeking Alpha  - Sep 24, 2014 Aradigm Corporation  is a Hayward, California-based biotechnology company focused on the development and commercialization of drugs delivered by inhalation for the severe respiratory diseases."
p9
aS'Aradigm Corp  Files Form 4 Insider Selling : Juergen Kurt Froehlich ... Energy Index - Apr 7, 2017 Aradigm Corp : Juergen Kurt Froehlich , Chief Medical Officer of Aradigm Corp sold 3,765 shares on Apr 4, 2017.Aradigm  Given Daily Coverage Optimism Score of 0.50 - The Cerbat Gem'
p10
a.